Jasper Therapeutics Inc. (JSPR)
NASDAQ: JSPR
· Real-Time Price · USD
3.04
0.01 (0.33%)
At close: Aug 15, 2025, 2:20 PM
0.33% (1D)
| Bid | 3.02 |
| Market Cap | 45.67M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -78.78M |
| EPS (ttm) | -6.05 |
| PE Ratio (ttm) | -0.5 |
| Forward PE | -0.68 |
| Analyst | Buy |
| Ask | 3.08 |
| Volume | 125,289 |
| Avg. Volume (20D) | 657,356 |
| Open | 3.04 |
| Previous Close | 3.03 |
| Day's Range | 2.94 - 3.08 |
| 52-Week Range | 2.27 - 26.05 |
| Beta | 2.71 |
About JSPR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol JSPR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for JSPR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+21.85%
Jasper Therapeutics shares are trading higher afte...
Unlock content with
Pro Subscription
1 month ago
-55.1%
Jasper Therapeutics shares are trading lower after the company reported an 89% response rate in its Urticaria study and will halt the program.
1 month ago · https://www.marketscreener.com
Jasper Therapeutics Announces Corporate Reorganization and Other Cost Cutting Measures to Extend Cash RunwayJasper Therapeutics, Inc. announced a corporate reorganization to extend its cash runway, including a workforce reduction of approximately 50%. Jasper has refined its operating plan to focus on its br...
